Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL709855

Fc1ccccc1COc1ccc(OCc2ccccc2)cc1-c1nc2cccnc2[nH]1.O=C(O)C(F)(F)F

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMO Q99835 1/20 0.41
PPARG P37231 1/20 0.41
PTPN1 P18031 5/20 0.40
PTPN2 P17706 3/20 0.39
CDC25B P30305 3/20 0.39
PDE5A O76074 1/20 0.38
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
CYP3A4 P08684 1/20 0.38
LRRK2 Q5S007 2/20 0.38
CYP1A1 P04798 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP1B1 Q16678 1/20 0.37
PARP15 Q460N3 1/20 0.37
PARP10 Q53GL7 1/20 0.37
SGMS2 Q8NHU3 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL711226 0.93 SMO (0.41) SMOPPARGPTPN1PTPN2CDC25B
SCHEMBL10206637 0.93 CYP3A4 (0.43) SMOPTPN1PTPN2CDC25BPDE5A
Trifluoroacetic Acid SCHEMBL709554 0.93 CYP3A4 (0.43) PPARGPDE5APDE4APDE4BPDE4C
Trifluoroacetic Acid SCHEMBL712956 0.89 GPR132 (0.45) PPARGPTPN1LRRK2MEN1KMT2A
Trifluoroacetic Acid SCHEMBL712435 0.89 SMO (0.40) SMOPPARGPTPN1PTPN2CDC25B
Trifluoroacetic Acid SCHEMBL713332 0.88 KMT2A (0.41) SMOPTPN1PDE5APDE4APDE4B
Trifluoroacetic Acid SCHEMBL711595 0.88 LRRK2 (0.43) PPARGPDE5APDE4APDE4BPDE4C
Trifluoroacetic Acid SCHEMBL711105 0.86 CYP1A1 (0.41) SMOPTPN1PTPN2CDC25BCYP1A1
SCHEMBL2668132 0.86 CYP3A4 (0.43) SMOPTPN1PTPN2CDC25BPDE5A
Trifluoroacetic Acid SCHEMBL711971 0.86 CYP3A4 (0.43) PDE5APDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1940837-B1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA PHARMACEUTICAL (JP) 2012-11-07 EP disclosed
US-8124617-B2 Imidazopyridine compounds TAKEDA SAN DIEGO, INC. (US) 2012-02-28 US disclosed
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA SAN DIEGO, INC. 2010-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS GCK, GCKR, KHK SMO 4431/4885PPARG 991/4885PTPN1 3316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.